产品编号 :
Cas No. :
CAS No. |
172733-08-3 |
|---|---|
中文名称 |
2-((3-(2-氨基-2-氧代乙酰基)-1-苄基-2-乙基-1H-吲哚-4-基)氧基)乙酸甲酯 |
英文名称 |
Methyl 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate |
别名 |
Varespladib methyl | VARESPLADIB METHYL ESTER [MI] | Varespladib methyl (USAN) | Varespladib methyl ester | HY-17448 | SCHEMBL25678 | A-002 | SB16537 | methyl 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate | S 3013 | Methyl ((3-(am |
标准英文名 |
methyl 2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetate |
MDL No. |
MFCD09833542 |
分子式 |
C22H22N2O5 |
分子量 |
394.43 |
精确分子量 |
394.15 |
SMILES |
O=C(OC)COC1=C(C(C(C(N)=O)=O)=C(CC)N2CC3=CC=CC=C3)C2=CC=C1 |
标准SMILES |
COC(=O)COC1C=CC=C2C=1C(=C(CC)N2CC1C=CC=CC=1)C(=O)C(N)=O |
用途 |
Varespladib methyl (A-002; LY333013) is a selective phospholipase A2 (PLA2) inhibitor used as an orally administered prodrug that is metabolized to LY315920; it demonstrates potent inhibition of secretory PLA2 (sPLA2) at nanomolar and picomolar concentrations against 28 medically important snake venoms from six continents. |
InChIKey |
VJYDOJXJUCJUHL-UHFFFAOYSA-N |
|
|
评论 |
|---|